Routine use of the Impella CP microaxial flow pump did not improve outcomes and may have contributed to deaths among patients undergoing high-risk percutaneous coronary intervention (PCI), according ...
Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results